These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 23056634)

  • 21. Expression of BLyS and its receptors in B-cell non-Hodgkin lymphoma: correlation with disease activity and patient outcome.
    Novak AJ; Grote DM; Stenson M; Ziesmer SC; Witzig TE; Habermann TM; Harder B; Ristow KM; Bram RJ; Jelinek DF; Gross JA; Ansell SM
    Blood; 2004 Oct; 104(8):2247-53. PubMed ID: 15251985
    [TBL] [Abstract][Full Text] [Related]  

  • 22. TACI-Ig induces immune balance of Th cells in MLN via BLyS/APRIL-receptors signaling in rats with adjuvant-induced arthritis.
    Qin Q; Chang Y; Wang D; Wu Y; Zhang LL; Wei W
    Int Immunopharmacol; 2011 Dec; 11(12):2167-75. PubMed ID: 21996540
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tumor necrosis factor (TNF) receptor superfamily member TACI is a high affinity receptor for TNF family members APRIL and BLyS.
    Wu Y; Bressette D; Carrell JA; Kaufman T; Feng P; Taylor K; Gan Y; Cho YH; Garcia AD; Gollatz E; Dimke D; LaFleur D; Migone TS; Nardelli B; Wei P; Ruben SM; Ullrich SJ; Olsen HS; Kanakaraj P; Moore PA; Baker KP
    J Biol Chem; 2000 Nov; 275(45):35478-85. PubMed ID: 10956646
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Enhanced immunogenicity of pneumococcal surface adhesin A (PsaA) in mice via fusion to recombinant human B lymphocyte stimulator (BLyS).
    Gor DO; Ding X; Li Q; Sultana D; Mambula SS; Bram RJ; Greenspan NS
    Biol Direct; 2011 Feb; 6():9. PubMed ID: 21306646
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Selective killing of Burkitt's lymphoma cells by mBAFF-targeted delivery of PinX1.
    Zhang L; Jiang Y; Zheng Y; Zeng Y; Yang Z; Huang G; Liu D; Gao M; Shen X; Wu G; Yan X; He F
    Leukemia; 2011 Feb; 25(2):331-40. PubMed ID: 21102426
    [TBL] [Abstract][Full Text] [Related]  

  • 26. BLyS expression and JNK activation may form a feedback loop to promote survival and proliferation of multiple myeloma cells.
    Xu G; Shen XJ; Pu J; Chu SP; Wang XD; Wu XH; Sun CJ; Zhang X; Zhu BL; Ju SQ
    Cytokine; 2012 Nov; 60(2):505-13. PubMed ID: 22850273
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Atacicept (TACI-Ig) inhibits growth of TACI(high) primary myeloma cells in SCID-hu mice and in coculture with osteoclasts.
    Yaccoby S; Pennisi A; Li X; Dillon SR; Zhan F; Barlogie B; Shaughnessy JD
    Leukemia; 2008 Feb; 22(2):406-13. PubMed ID: 18046446
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sortase-catalyzed in vitro functionalization of a HER2-specific recombinant Fab for tumor targeting of the plant cytotoxin gelonin.
    Kornberger P; Skerra A
    MAbs; 2014; 6(2):354-66. PubMed ID: 24492291
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Suppression of hepatoma tumor growth by systemic administration of the phytotoxin gelonin driven by the survivin promoter.
    Wang Z; Zhou X; Li J; Liu X; Chen Z; Shen G; Guan T; Ye N; Wei X; Huang N; Yang L; Wei Y; Li J
    Neoplasma; 2013; 60(5):469-79. PubMed ID: 23790164
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The B lymphocyte stimulator receptor-ligand system in hepatitis C virus-induced B cell clonal disorders.
    Landau DA; Rosenzwajg M; Saadoun D; Klatzmann D; Cacoub P
    Ann Rheum Dis; 2009 Mar; 68(3):337-44. PubMed ID: 18434450
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The B Cell-Stimulatory Cytokines BLyS and APRIL Are Elevated in Human Periodontitis and Are Required for B Cell-Dependent Bone Loss in Experimental Murine Periodontitis.
    Abe T; AlSarhan M; Benakanakere MR; Maekawa T; Kinane DF; Cancro MP; Korostoff JM; Hajishengallis G
    J Immunol; 2015 Aug; 195(4):1427-35. PubMed ID: 26150532
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Convergent potency of internalized gelonin immunotoxins across varied cell lines, antigens, and targeting moieties.
    Pirie CM; Hackel BJ; Rosenblum MG; Wittrup KD
    J Biol Chem; 2011 Feb; 286(6):4165-72. PubMed ID: 21138845
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lymphoma B cells evade apoptosis through the TNF family members BAFF/BLyS and APRIL.
    He B; Chadburn A; Jou E; Schattner EJ; Knowles DM; Cerutti A
    J Immunol; 2004 Mar; 172(5):3268-79. PubMed ID: 14978135
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Expression and significance of BLyS/April in patients with acute idiopathic thrombocytopenic purpura].
    Wang GB; Li CR; Li CG; Wang Y; Yang J
    Zhonghua Xue Ye Xue Za Zhi; 2008 Sep; 29(9):595-8. PubMed ID: 19175985
    [TBL] [Abstract][Full Text] [Related]  

  • 35. BLyS and B cell homeostasis.
    Woodland RT; Schmidt MR; Thompson CB
    Semin Immunol; 2006 Oct; 18(5):318-26. PubMed ID: 16931037
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An optimized B lymphocyte stimulator (BLyS) antagonist peptide inhibits the interaction of BLyS with BCMA.
    Tian Y; Zhu YF; Wu Z; Feng JN; Li Y; Shen BF; Sun J
    Biotechnol Lett; 2013 Apr; 35(4):523-8. PubMed ID: 23242501
    [TBL] [Abstract][Full Text] [Related]  

  • 37. B-lymphocyte stimulator (BLyS) stimulates immunoglobulin production and malignant B-cell growth in Waldenstrom macroglobulinemia.
    Elsawa SF; Novak AJ; Grote DM; Ziesmer SC; Witzig TE; Kyle RA; Dillon SR; Harder B; Gross JA; Ansell SM
    Blood; 2006 Apr; 107(7):2882-8. PubMed ID: 16304043
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular tumor targeting of gelonin by fusion with F3 peptide.
    Ham SH; Min KA; Shin MC
    Acta Pharmacol Sin; 2017 Jun; 38(6):897-906. PubMed ID: 28414205
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Poly(I:C) induces BLyS-expression of airway fibroblasts through phosphatidylinositol 3-kinase.
    Yamada T; Lizhong S; Takahashi N; Kubo S; Narita N; Suzuki D; Takabayashi T; Kimura Y; Fujieda S
    Cytokine; 2010 May; 50(2):163-9. PubMed ID: 20089415
    [TBL] [Abstract][Full Text] [Related]  

  • 40. B-cell homeostasis requires complementary CD22 and BLyS/BR3 survival signals.
    Smith SH; Haas KM; Poe JC; Yanaba K; Ward CD; Migone TS; Tedder TF
    Int Immunol; 2010 Aug; 22(8):681-91. PubMed ID: 20513733
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.